Impact of Human Papillomavirus on Oropharyngeal Cancer Biology and Response to Therapy
- 1 August 2013
- journal article
- research article
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 46 (4) , 521-543
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Robotic Surgery for Oropharynx Cancer: Promise, Challenges, and Future DirectionsCurrent Oncology Reports, 2012
- Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancerThe Laryngoscope, 2011
- The role of HPV in head and neck cancer and review of the HPV vaccinePreventive Medicine, 2011
- Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directionsEuropean Archives of Oto-Rhino-Laryngology, 2011
- Correlation of Cellular Immunity With Human Papillomavirus 16 Status and Outcome in Patients With Advanced Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- Oncogenic activities of human papillomavirusesVirus Research, 2009
- Update on Molecular Diagnostic Tests in Head and Neck CancerSeminars in Oncology, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008